pfizer

Pfizer asks FDA for approval to expand omicron booster to 5- to 11-year-olds

By Associated Press

Pfizer is asking the Food and Drug Administration to expand use of its updated COVID-19 booster shot to children ages 5 to 11.

Moderna sues Pfizer and BioNTech, alleges companies violated mRNA patents with COVID vaccines

By Tom Murphy, Associated Press

COVID-19 vaccine maker Moderna is suing its main competitors Pfizer and the German drugmaker BioNTech, accusing the rivals of copying Moderna's technology in order to make their own vaccine.

Pfizer says its COVID shots are 73 percent effective in children under 5

By Associated Press

Pfizer's says its COVID-19 vaccine was 73% effective in protecting children younger than 5 as omicron spread in the spring.

News Wrap: Pfizer seeks FDA approval for new COVID vaccine targeting omicron subvariants

In our news wrap Monday, Pfizer asked the FDA to authorize a new COVID vaccine targeting omicron subvariants, Dr. Anthony Fauci will step down from his post in December, Russia blamed Ukraine for a deadly car bombing near Moscow, Pakistan…

Continue watching

Pfizer continues pandemic-revenue buying spree with $5.4 billion hematology deal

By Tom Murphy, Michelle Chapman, Associated Press

Pfizer is buying sickle cell drug maker Global Blood Therapeutics in an approximately $5.4 billion deal as it looks to accelerate growth after its revenue soared during the pandemic.

CDC recommends COVID vaccines for children under 5

By Mike Stobbe, Associated Press

The head of the Centers for Disease Control and Prevention announced the decision hours after an advisory panel voted unanimously that vaccines should be made available to children as young as 6 months.

Pfizer COVID vaccine safe for kids under 5, FDA review finds

By Matthew Perrone, Mike Stobbe, Associated Press

The review from the Food and Drug Administration is a key step toward an expected decision to begin vaccinating babies, toddlers and preschoolers as soon as June 21.

Three Pfizer COVID shots protect children under 5, company says

By Lauran Neergaard, Associated Press

Pfizer says three small doses of its COVID-19 vaccine protect kids under 5 and that it plans to give the data to U.S. regulators later this week.

CDC urges Pfizer COVID booster for children ages 5 to 11

By Lauran Neergaard, Associated Press

U.S. health advisers are urging a booster dose of Pfizer's COVID-19 vaccine for kids ages 5 to 11. The Centers for Disease Control and Prevention quickly signed off on the advice.